Clinical trial
Phase 1/2 Study of Vactosertib (TEW-7197) Monotherapy in Patients With Low or Intermediate Myelodysplastic Syndromes
NCT03074006 is registered in ClinicalTrials.gov with MedPacto, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1/2 Study of Vactosertib (TEW-7197) Monotherapy in Patients With Low or Intermediate Myelodysplastic Syndromes
- Lead sponsor
- MedPacto, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 4, 2018
- Completion date
- December 31, 2019
- Enrollment
- 9 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.